The most commonly used PET radiopharmaceutical is FDG (18FluorDesoxyGlucose). FDG is used to examine glucose metabolism, which can be elevated in tumor diseases or inflammation, for example. In FDG-PET examinations of the brain, areas with a reduced glucose metabolism are of particular interest, e.g. in the context of epilepsy and dementia diagnostics.
Apart from this, there are other radiopharmaceuticals by which very specific targets in the body can be detected and imaged. Due to the necessary special delivery and short life of the PET radiopharmaceuticals used, it is important to make an appointment in time and to keep the appointment on time.